Regeneron and Sanofi Announce Dupixent Outperformance over Xolair in Phase 4 EVEREST Trial Results for CRSwNP and Asthma
15/6 17:30
Dupixent surpassed Xolair in treating CRSwNP and asthma, improving symptoms and quality of life significantly....
|
|
|
15/6 17:30
Dupixent surpassed Xolair in treating CRSwNP and asthma, improving symptoms and quality of life significantly....